Literature DB >> 22986700

Role of whole-body 64-slice multidetector computed tomography in treatment planning for multiple myeloma.

Ahmed Abdel Khalek Abdel Razek1, Amany Ezzat, Emad Azmy, Nehal Tharwat.   

Abstract

PURPOSE: The authors evaluated the role of whole-body 64-slice multidetector computed tomography (WB-MDCT) in treatment planning for multiple myeloma.
MATERIAL AND METHODS: This was a prospective study of 28 consecutive patients with multiple myeloma (19 men, nine women; age range, 51-73 years; mean age, 60 years) who underwent WB-MDCT and conventional radiography (CR) of the skeleton. The images were interpreted for the presence of bony lesions, medullary lesions, fractures and extraosseous lesions. We evaluated any changes in treatment planning as a result of WB-MDCT findings.
RESULTS: WB-MDCT was superior to CR for detecting bony lesions (p=0.001), especially of the spine (p=0.001) and thoracic cage (p=0.006). WB-MDCT upstaged 14 patients, with a significant difference in staging (p=0.002) between WB-MDCT and CR. Medullary involvement either focal (n=6) or diffuse (n=3) had a positive correlation with the overall score (r=0.790) and stage (r=0.618) of disease. Spine fractures were better detected at WB-MDCT (n=4) than at CR (n=2). Extraosseous soft tissue lesions (n=7) were detected only at WB-MDCT. Findings detected at the WB-MDCT led to changes in the patient's treatment plan in 39% of cases. Upstaging of seven patients (25%) altered the medical treatment plan, and four of 28 (14%) patients required additional radiotherapy (7%) and vertebroplasty (7%).
CONCLUSIONS: We conclude that WB-MDCT has an impact on treatment planning and prognosis in patients with multiple myeloma, as it has high rate of detecting cortical and medullary bone lesions, spinal fracture and extraosseous lesions. This information may alter treatment planning in multiple myeloma due to disease upstaging and detection of spine fracture and extraosseous spinal lesions.

Entities:  

Mesh:

Year:  2012        PMID: 22986700     DOI: 10.1007/s11547-012-0880-0

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  32 in total

1.  Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.

Authors:  Marius Horger; Claus D Claussen; Ulrike Bross-Bach; Reinhard Vonthein; Tobias Trabold; Martin Heuschmid; Christina Pfannenberg
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

2.  The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.

Authors:  Massimo Castellani; Marco Carletto; Luca Baldini; Rossella Calori; Virgilio Longari; Davide Soligo; Luca Dellavedova; Paolo Gerundini
Journal:  Clin Nucl Med       Date:  2010-01       Impact factor: 7.794

Review 3.  Imaging in multiple myeloma.

Authors:  Stefan Delorme; Andrea Baur-Melnyk
Journal:  Recent Results Cancer Res       Date:  2011

4.  The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma.

Authors:  Marius Horger; Lothar Kanz; Barbara Denecke; Reinhard Vonthein; Philippe Pereira; Claus D Claussen; Christoph Driessen
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

5.  Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.

Authors:  Christopher J Hanrahan; Carl R Christensen; Julia R Crim
Journal:  Radiographics       Date:  2010-01       Impact factor: 5.333

6.  Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

Authors:  Andrea Baur-Melnyk; Sonja Buhmann; Christoph Becker; Stefan Oswald Schoenberg; Nicola Lang; Reiner Bartl; Maximilian Ferdinand Reiser
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

Review 7.  Imaging in multiple myeloma.

Authors:  Stefan Delorme; Andrea Baur-Melnyk
Journal:  Eur J Radiol       Date:  2009-03-09       Impact factor: 3.528

8.  Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters.

Authors:  M Horger; P Pereira; C D Claussen; L Kanz; R Vonthein; B Denecke; C Driessen
Journal:  Br J Radiol       Date:  2008-05       Impact factor: 3.039

9.  Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience.

Authors:  Chieh Lin; Alain Luciani; Karim Belhadj; Patrick Maison; Alexandre Vignaud; Jean-François Deux; Pierre Zerbib; Frédéric Pigneur; Emmanuel Itti; Hicham Kobeiter; Corinne Haioun; Alain Rahmouni
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

10.  Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).

Authors:  T G Gleeson; J Moriarty; C P Shortt; J P Gleeson; P Fitzpatrick; B Byrne; J McHugh; M O'Connell; P O'Gorman; S J Eustace
Journal:  Skeletal Radiol       Date:  2008-11-14       Impact factor: 2.199

View more
  9 in total

Review 1.  Oncologist perspective: role of imaging in myeloma.

Authors:  Yael N Shapiro; Elizabeth K O'Donnell
Journal:  Skeletal Radiol       Date:  2021-07-17       Impact factor: 2.199

2.  Computed Tomography Assessment of Hepatic Metastases of Breast Cancer with Revised Response Evaluation Criteria in Solid Tumors (RECIST) Criteria (Version 1.1): Inter-Observer Agreement.

Authors:  Fady Emil Ibrahim Ghobrial; Manal Salah Eldin; Ahmed Abdel Khalek Abdel Razek; Nadia Ibrahim Atwan; Sameh Sayed Ahmed Shamaa
Journal:  Pol J Radiol       Date:  2017-10-20

3.  Inter-Observer Agreement of Whole-Body Computed Tomography in Staging and Response Assessment in Lymphoma: The Lugano Classification.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sameh Shamaa; Mahmoud Abdel Lattif; Hanan Hamid Yousef
Journal:  Pol J Radiol       Date:  2017-08-23

4.  Value of virtual monochromatic spectral images with metal artifact reduction algorithm in dual-energy computed tomography-guided microcoil localization of pulmonary nodules.

Authors:  Zhuo Liu; Zhuolu Zhang; Chen Chen; Nan Hong
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).

Authors:  Corinna Storz; Roland Bares; Martin Ebinger; Rupert Handgretinger; Ilias Tsiflikas; Jürgen F Schäfer
Journal:  BMC Med Imaging       Date:  2019-08-20       Impact factor: 1.930

6.  Correlations between apparent diffusion coefficient values of WB-DWI and clinical parameters in multiple myeloma.

Authors:  Bei Zhang; Bingyang Bian; Zhiwei Zhao; Fang Lin; Zining Zhu; Mingwu Lou
Journal:  BMC Med Imaging       Date:  2021-06-08       Impact factor: 1.930

7.  Thoracoscopic segmentectomy assisted by three-dimensional computed tomography bronchography and angiography for lung cancer in a patient living with situs inversus totalis: A case report.

Authors:  Yun-Jiang Wu; Yang Bao; Ya-Li Wang
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

8.  Craniocerebral metastases from a supraglottic squamous cell carcinoma: A case report and literature review.

Authors:  Moisés León-Ruiz; Julián Benito-León
Journal:  Clin Case Rep       Date:  2019-10-02

9.  Whole-body diffusion-weighted imaging with background body signal suppression in the detection of osseous and extra-osseous metastases.

Authors:  Ahmed Abdel Razek; Ahmed Tawfik; Mariam Abdel Rahman; Saleh Teima
Journal:  Pol J Radiol       Date:  2019-11-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.